130 related articles for article (PubMed ID: 22278996)
1. Preliminary study of the anticancer applications of mesoporous materials functionalized with the natural product betulinic acid.
Sánchez-Muñoz S; Gómez-Ruiz S; Pérez-Quintanilla D; Morante-Zarcero S; Sierra I; Prashar S; Paschke R; Kaluđerović GN
ChemMedChem; 2012 Apr; 7(4):670-9. PubMed ID: 22278996
[TBL] [Abstract][Full Text] [Related]
2. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
3. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid.
Tan JM; Karthivashan G; Arulselvan P; Fakurazi S; Hussein MZ
Drug Des Devel Ther; 2014; 8():2333-43. PubMed ID: 25429205
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content.
Kaluderović GN; Pérez-Quintanilla D; Zizak Z; Juranić ZD; Gómez-Ruiz S
Dalton Trans; 2010 Mar; 39(10):2597-608. PubMed ID: 20179853
[TBL] [Abstract][Full Text] [Related]
5. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
6. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
7. Investigating the potential of functionalized MCM-41 on adsorption of Remazol Red dye.
Santos DO; de Lourdes Nascimento Santos M; Costa JA; de Jesus RA; Navickiene S; Sussuchi EM; de Mesquita ME
Environ Sci Pollut Res Int; 2013 Jul; 20(7):5028-35. PubMed ID: 23334547
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the divergent activities of betulinic acid via neoglycosylation.
Goff RD; Thorson JS
Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
[TBL] [Abstract][Full Text] [Related]
9. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264
[TBL] [Abstract][Full Text] [Related]
10. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
[TBL] [Abstract][Full Text] [Related]
12. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate.
Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new multivalent metal ion functionalized mesoporous silica and studies of their enhanced antimicrobial and cytotoxicity activities.
Chirra S; Siliveri S; Gangalla R; Goskula S; Gujjula SR; Adepu AK; Anumula R; Sivasoorian SS; Wang LF; Narayanan V
J Mater Chem B; 2019 Dec; 7(45):7235-7245. PubMed ID: 31664291
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-α-caspase-3 activity.
Dash SK; Chattopadhyay S; Ghosh T; Dash SS; Tripathy S; Das B; Bag BG; Das D; Roy S
Biomed Pharmacother; 2015 May; 72():144-57. PubMed ID: 26054689
[TBL] [Abstract][Full Text] [Related]
18. Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines.
Zhao J; Li R; Pawlak A; Henklewska M; Sysak A; Wen L; Yi JE; Obmińska-Mrukowicz B
In Vivo; 2018; 32(5):1081-1088. PubMed ID: 30150429
[TBL] [Abstract][Full Text] [Related]
19. Betulinic acid and its derivatives: a patent review (2008-2013).
Csuk R
Expert Opin Ther Pat; 2014 Aug; 24(8):913-23. PubMed ID: 24909232
[TBL] [Abstract][Full Text] [Related]
20. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]